These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 551088)

  • 41. Cefaclor and cefadroxil: a commentary on their properties and possible indications for use in pediatrics.
    Ginsburg CM; McCracken GH
    J Pediatr; 1980 Feb; 96(2):340-2. PubMed ID: 7351610
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of cefaclor.
    Derry JE
    Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections.
    Ballantyne FN
    Clin Ther; 1985; 7(4):487-91. PubMed ID: 4016827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Investigations on the excretion of cefaclor in human bile (author's transl)].
    Müller O; Rückert U; Fabricius K
    Infection; 1979; 7 Suppl 6():624-7. PubMed ID: 551091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical results of cefaclor treatment of infections of oral regions].
    Yoshida Y; Kita T; Kanematsu N; Sato K; Kawata K; Fukuta N; Sato J
    Jpn J Antibiot; 1984 Mar; 37(3):318-28. PubMed ID: 6737694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experience with cefaclor in the treatment of ear, nose and throat infections. Indications for cefaclor therapy (author's transl)].
    Federspil P; Bach R; Weich C; Wilhelm HJ; Tiesler E; Schätzle W
    Infection; 1979; 7 Suppl 6():609-14. PubMed ID: 551089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
    Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
    J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of an antibiotic combination (amoxicillin + clavulanic acid) and cefaclor in the treatment of acute or flare-ups of chronic bronchopneumopathies].
    Moreo G; Sardi C; Braschi R; Nani M; Remotti G
    Clin Ter; 1988 Sep; 126(6):411-6. PubMed ID: 2974402
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
    Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
    Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cefaclor: clinical and bacteriological evaluation in 45 cases.
    Gómez-Lus R; Martinez-Piriz R; Espinosa C; Guillen G; Gómez-Agudo G; Clavel A
    Postgrad Med J; 1979; 55 Suppl 4():70-1. PubMed ID: 44909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Penetration of cefaclor into bronchial mucosa.
    Marlin GE; Nicholls AJ; Funnell GR; Bradbury R
    Thorax; 1984 Nov; 39(11):813-7. PubMed ID: 6505987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical trials on pediatric lower-respiratory-tract infection: results and comments with cefetamet pivoxil.
    Paupe J; Sarbeji M; Scheinmann P; Delacourt C; Sorin M
    Chemotherapy; 1992; 38 Suppl 2():29-32. PubMed ID: 1516462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cefaclor treatment of upper and lower respiratory tract infections caused by Moraxella catarrhalis.
    Oberlin JA; Hyslop DL
    Pediatr Infect Dis J; 1990 Jan; 9(1):41-4. PubMed ID: 2105479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pharmacokinetics of cefaclor in subjects with normal renal function and in uraemic patients (author's transl)].
    Leroy A; Humbert G; Fillastre JP
    Therapie; 1981; 36(5):533-40. PubMed ID: 7323991
    [No Abstract]   [Full Text] [Related]  

  • 55. Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
    Pelletier LL
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S238-43; discussion S244-5. PubMed ID: 1617044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
    Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
    Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cefadroxil compared with cefaclor in the treatment of streptococcal pneumonia in adults.
    ZeLuff B; Catchpole M; Lowe P; Koornhof H; Gentry L
    Drugs; 1986; 32 Suppl 3():39-42. PubMed ID: 3803252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study of cefaclor versus amoxicillin in urinary tract infections (author's transl)].
    Naber K; Kaldewey W
    Infection; 1979; 7 Suppl 6():617-21. PubMed ID: 399250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Laboratory and clinical studies of cefaclor in Japan.
    Fujii R
    Postgrad Med J; 1979; 55 Suppl 4():88-92. PubMed ID: 398486
    [No Abstract]   [Full Text] [Related]  

  • 60. Cefaclor safety profile: a ten-year review.
    Hyslop DL
    Clin Ther; 1988; 11 Suppl A():83-94. PubMed ID: 3242837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.